Muncy, Geissler, Olds & Lowe, P.C.
Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells
Embodiments relate to serological markers for detecting the colorectal cancer and applications of the serological markers. A phospholipid scramblase1 (PLSCR1), a stomatin-like protein 2 (STOML2) or a transport protein Sec61β (SEC61β) increases expression in the blood at the earlier stage of the colorectal cancer. Detecting the expression of the PLSCR1, STOML2 or SEC61β protein or an induced autoantibody of each protein in a blood sample is used to diagnose the colorectal cancer. Moreover, the serological marker improves the detection efficiency and the sensitivity in detecting the colorectal cancer and is used to predict the prognosis. The serological markers are applied in preparing a detection device or inhibiting the growth of the colorectal cancer cells.
CHANG GUNG UNIVERSITY
C G G C
C07K G01N G01N C12N
additional inventional inventional additional
Jinn-Shiun Kuei-Tien Err-Cheng Jau-Song Yu-Sun
Chen Chen Chan Yu Chang